Log in to search using one of your social media accounts:

 

Science News » NIH Announces Awards for BRAIN Initiative Neuroethics Research
The NIH BRAIN Initiative has awarded grants to five teams of experts who will study the neuroethical issues surrounding the use of deep brain stimulation in neuropsychiatric and movement disorders and appropriate consent for brain research. (Source: National Institute of Mental Health)
Source: National Institute of Mental Health - November 6, 2017 Category: Psychiatry Authors: Barbara McMakin Source Type: news

OHSU study validates deep brain surgery while asleep for Parkinson's patients
Most brain surgeons in the U.S. perform the procedure with patients awake the whole time. Not at OHSU.Most surgeons perform deep brain stimulation to ease the effects of Parkinson ’s disease while the patient is awake. Not at Oregon Health& Science University. OHSU neurologists stopped doing awake surgeries in January 2011. They pioneered a technique to accurately map the brain before and during the procedure, allowing the patient to remain asleep with general anesthesia all the while. With DBS, surgeons implant electrodes into specific areas of the brain that control movement in order to improve motor function a...
Source: bizjournals.com Health Care News Headlines - November 3, 2017 Category: Health Management Authors: Elizabeth Hayes Source Type: news

OHSU study validates deep brain surgery while asleep for Parkinson's patients
Most brain surgeons in the U.S. perform the procedure with patients awake the whole time. Not at OHSU.Most surgeons perform deep brain stimulation to ease the effects of Parkinson ’s disease while the patient is awake. Not at Oregon Health& Science University. OHSU neurologists stopped doing awake surgeries in January 2011. They pioneered a technique to accurately map the brain before and during the procedure, allowing the patient to remain asleep with general anesthesia all the while. With DBS, surgeons implant electrodes into specific areas of the brain that control movement in order to improve motor function a...
Source: bizjournals.com Health Care:Biotechnology headlines - November 3, 2017 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

Abbott launches Proclaim DRG neurostim
Abbott (NYSE:ABT) said today it launched its Proclaim dorsal root ganglion neurostimulator system designed to treat pain in patients with complex regional pain syndrome of the lower limbs. The company’s Proclaim DRG system is designed to be used via Bluetooth with an Apple (NSDQ:AAPL) iPod touch as a system controller and is magnetic resonance-conditional and recharge free, all upgrades from previous versions of the device, the Abbott Park, Ill.-based company said. Abbott said it originally launched the DRG therapy system in 2016 and data from the Accurate study of it showed the system delivers “...
Source: Mass Device - October 16, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Neuromodulation/Neurostimulation Pain Management Abbott Source Type: news

MassDevice.com +5 | The top 5 medtech stories for October 13, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. 10 tips for selecting and managing a medtech development partner There many things to consider when searching for and interacting with a product development firm – and the stakes are high! Most early-stage medical device ...
Source: Mass Device - October 13, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Abbott study shows promise for DBS therapy for treatment-resistant depression
This study is a strong example of how our therapies can contribute to the innovation taking place within the broad field of neuroscience. We applaud the researchers who led this study and look forward to future advancements to support the care of people suffering from chronic, treatment-resistant depression,” Abbott neuromod division medical director Dr. Allen Burton said in a prepared statement. Abbott said that currently its DBS system is only indicated for treating essential tremor and Parkinson’s disease. Earlier this month, Abbott closed its $5.3 billion buy of diagnostics giant Alere (NYSE:ALR),...
Source: Mass Device - October 13, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Neuromodulation/Neurostimulation Abbott Source Type: news

New Data Shows That For Some Patients, Deep Brain Stimulation May Address Chronic Depression
- A new dataset published in The Lancet: Psychiatry highlights the largest prospective study in DBS for chronic, treatment-resistant depression (Source: Abbott.com)
Source: Abbott.com - October 11, 2017 Category: Pharmaceuticals Source Type: news

Deep brain stimulation helps Parkinson ’s patients regain independence
New technology called deep brain stimulation may offer an alternative to conventional treatment of patients with Parkinson ’s disease. (Source: Yale Science and Health News)
Source: Yale Science and Health News - September 21, 2017 Category: Universities & Medical Training Source Type: news

Intermittent electrical brain stimulation improves memory
(Medical College of Georgia at Augusta University) Intermittent electrical stimulation of an area deep inside the brain that degenerates in Alzheimer's appears to improve working memory, scientists report.Conversely, continuous deep brain stimulation, like the type used for Parkinson's and currently under study in humans with Alzheimer's, impairs memory, according to study results in adult non-human primates reported in the journal Current Biology. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - September 7, 2017 Category: International Medicine & Public Health Source Type: news

Deep Brain Stimulation May Offer Hope for Severe Schizophrenia Deep Brain Stimulation May Offer Hope for Severe Schizophrenia
Patients with treatment-resistant schizophrenia may benefit from deep brain stimulation, although the surgical risks need to be considered, say Spanish researchers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 5, 2017 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Rush testing if genetic clues identify best candidates for Parkinson's surgery
(Rush University Medical Center) A new clinical trial is testing whether a common genetic mutation makes Parkinson's Disease patients more likely to suffer cognitive decline after deep brain stimulation surgery. This information would help neurologists identify the best candidates for this procedure and targets different brain areas based on that genetic information. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 31, 2017 Category: International Medicine & Public Health Source Type: news

Driving ability in Parkinson's disease - Buhmann C, Vesper J, Oelsner H.
About 60 % of all patients with Parkinson's disease (PD) and about 50 % of PD patients with deep brain stimulation (DBS) in possession of a driving license are active car-drivers. Parkinson patients, however, often display physical and/or psychological wea... (Source: SafetyLit)
Source: SafetyLit - August 17, 2017 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Mayo Clinic picks up 11% stake in neuromod startup NeuroOne
The Mayo Clinic as acquired an 10.9% stake in epilepsy treatment neuromod startup NeuroOne’s parent firm, according an SEC filing from the company. NeuroOne is developing a “thin film” electrode technology, originally from the University of Wisconsin, designed to be implanted in the brain. The film can detect irregular brain activity, accurate to single neurons, to pinpoint the source of seizures and tremors, according to the filing, and has been used in testing at the Mayo Clinic. The technology combines detection alongside deep brain stimulation treatment and ablation capabilities to monitor and treat i...
Source: Mass Device - August 7, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Neurological Neuromodulation/Neurostimulation Mayo Clinic neuroone Source Type: news

Researchers make steps towards closed-loop DBS system for essential tremor, Parkinsons
Researchers at the University of Washington say they developed an advanced deep brain stimulation system designed to treat essential tremor without constantly being “on,” allowing for longer battery life and better treatment. The system utilizes electrodes on top of the brain to sense movement in parts of the body that experience essential tremor, alongside a deep brain electrode to deliver stimulation only when it’s needed. Previous versions of deep brain stimulation systems delivered treatment at all times, with no way to turn the system off, even while the patient is asleep. Read the whole story on our...
Source: Mass Device - June 28, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Neurological Neuromodulation/Neurostimulation Medtronic Source Type: news

MassDevice.com +5 | The top 5 medtech stories for June 28, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Sirtex shares jump on restructuring plan, 15% headcount reduction Sirtex Medical saw shares jump today after revealing plans for a major restructuring as the company looks to cut its headcount and focus on its “profitable...
Source: Mass Device - June 28, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Medtronic wins CE Mark for SureTune3 deep-brain stimulation software
Medtronic (NYSE:MDT) said today that it won CE Mark approval in the European Union for its SureTune3 deep-brain stimulation software, which is designed to map lead locations and indicate the level of stimulation. The Fridley, Minn.-based Medtronic said its DBS devices are approved in the E.U. for treating Parkinson’s disease, dystonia, essential tremor, obsessive-compulsive disorder and epilepsy, claiming the portfolio as the only one to be full-body MR-conditional and able to operate during MRI scans. and is the only DBS complete portfolio that, under specific conditions, is full body MR conditional and can be ...
Source: Mass Device - June 28, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Neuromodulation/Neurostimulation Regulatory/Compliance Medtronic Source Type: news

Working Toward a World Without Parkinson ’s Disease
John L. Lehr is chief executive officer of the Parkinson’s Foundation. By John L. LehrNEW YORK, Jun 27 2017 (IPS)As one expert recently noted, if Parkinson’s were an infectious disease, we would call it an epidemic. Worldwide, 10 million people live with Parkinson’s disease, a number expected to double in the next 20 years. While there is no cure for Parkinson’s and no proven way to slow its progression, there is new reason to hope for a world without Parkinson’s. John L. LehrThe varied symptoms of Parkinson’s – including tremor, slowness, fatigue and cognitive difficulties –...
Source: IPS Inter Press Service - Health - June 27, 2017 Category: International Medicine & Public Health Authors: John Lehr Tags: Development & Aid Featured Global Headlines Health TerraViva United Nations Source Type: news

Correct connections are crucial
(Charit é - Universit ä tsmedizin Berlin) Working with colleagues from Harvard Medical School and W ü rzburg, researchers from Charit é - Universit ä tsmedizin Berlin have been examining the use of deep brain stimulation in the treatment of Parkison's disease in an attempt to optimize treatment effectiveness. The results, describing an effective network profile of deep brain stimulation has been reported in the journal Annals of Neurology*. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 22, 2017 Category: International Medicine & Public Health Source Type: news

First randomized controlled trial of DBS for chronic pain shows promise
(Cleveland Clinic) Deep brain stimulation (DBS) of the ventral striatum/anterior limb of the internal capsule is safe and feasible in addressing the affective component of pain in patients with post-stroke pain syndrome.Cleveland Clinic investigators reported findings from the first prospective, randomized, controlled trial of DBS for neuropathic pain in a presentation at the 2017 annual scientific meeting of the American Association of Neurological Surgeons. The study was also published in the May 2017 issue of Annals of Neurology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 20, 2017 Category: International Medicine & Public Health Source Type: news

Brain-Circuit-Based Therapies for OCD
I say it over and over again when I write about OCD. The evidence-based psychological treatment for obsessive-compulsive disorder is a type of Cognitive Behavioral Therapy known as exposure and response prevention (ERP). Medication is helpful for some individuals as well. With proper treatment, most people with OCD will improve. But what if you don’t? What if, after attempting these traditional therapies, there is no improvement and you are still suffering with severe OCD? While I’ve written before about some people with OCD erroneously being labeled treatment-resistant, there are indeed a small number of peopl...
Source: Psych Central - June 17, 2017 Category: Psychiatry Authors: Janet Singer Tags: Obsessive-Compulsive Disorder Personal Stories Psychology Psychotherapy Treatment Brain Medicine Nervous System Neuron Neuroscience Ocd Source Type: news

A noninvasive deep brain stimulation technique
Researchers designed a noninvasive way to stimulate cells deep in the brains of mice without affecting surrounding tissue. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - June 12, 2017 Category: Consumer Health News Source Type: news

Medtronic wins Health Canada nod for SureTune3 DBS software
Medtronic (NYSE:MDT) said today it won Health Canada approval for its SureTune3 software designed for programming deep brain stimulation therapy. The Fridley, Minn.-based company said the DBS Therapy system is licensed by Health Canada for treating diseases such as Parkinsons and for treating symptoms such as tremors through the application of mild electrical stimulation to precise targets in the brain. The SureTune3 provides patient-specific visualization of lead location and simulated volume of neural activation to aid physicians in decision making during the programming of DBS therapy treatments. Advancem...
Source: Mass Device - June 6, 2017 Category: Medical Devices Authors: Fink Densford Tags: Neurological Regulatory/Compliance Software / IT Medtronic Source Type: news

MassDevice.com +5 | The top 5 medtech stories for June 6, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Report: Valeant shopping sale of surgical eye biz Valeant Pharmaceuticals is looking to sell its Bausch & Lomb division’s surgical product assets to Carl Zeiss Meditec, according to a Bloomberg report. The surgical ey...
Source: Mass Device - June 6, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Boston Scientific wins CE Mark for Vercise Gevia DBS
Boston Scientific (NYSE:BSX) said today that it won CE Mark approval in the European Union for its Vercise Gevia deep-brain stimulation device for treating movement disorder symptoms. Marlborough, Mass.-based Boston Scientific said the new system features programming software called the Vercise Neural Navigator 2 with Stimview, designed to allow physicians to see images of the stimulation field while the Vercise Gevia is configured. The MR-conditional, rechargeable system also has an estimated battery life of 25 years, the company said. “Five years ago, Boston Scientific was the 1st to bring ...
Source: Mass Device - June 6, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Neuromodulation/Neurostimulation Regulatory/Compliance Wall Street Beat Boston Scientific Deep-brain stimulation Source Type: news

'All Scientific Hands On Deck' To End The Opioid Crisis
By Nora Volkow (Director, NIDA) and Francis Collins (Director, NIH) In 2015, 2 million people had a prescription opioid use disorder and 591,000 suffered from a heroin use disorder; prescription drug misuse alone cost the nation $78.5 billion in health care, law enforcement, and lost productivity. But while the scope of the crisis is staggering, it is not hopeless. We understand opioid addiction better than many other drug use disorders; there are effective strategies that can be implemented right now to save lives and to prevent and treat opioid addiction. At the National Rx Drug Abuse and Heroin Summit in Atlanta, GA las...
Source: Healthy Living - The Huffington Post - June 1, 2017 Category: Consumer Health News Source Type: news

Researchers develop non-invasive deep brain stimulation method
Researchers at MIT have developed a new method of electrically stimulating deep brain tissues without opening the skullSince 1997, more than 100,000 Parkinson ’s Disease patients have been treated with deep brain stimulation (DBS), a surgical technique that involves theimplantation of ultra-thin wire electrodes. The implanted device, sometimes referred to as a ‘brain pacemaker’, delivers electrical pulses to a structure called the subthalamic nucleus, located near the centre of the brain, and effectively alleviates many of the physical symptoms of the disease, such as tremor, muscle rigidity, and slowed m...
Source: Guardian Unlimited Science - June 1, 2017 Category: Science Authors: Mo Costandi Tags: Science Neuroscience Parkinson's disease Society Medical research Source Type: news

Medical News Today: Scientists develop noninvasive approach to electrical deep brain stimulation
Scientists have developed a way to stimulate deep inside the brain with electrodes on the scalp, removing the need for invasive surgery to implant them. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 1, 2017 Category: Consumer Health News Tags: Neurology / Neuroscience Source Type: news

Scientists develop noninvasive approach to electrical deep brain stimulation
Scientists have developed a way to stimulate deep inside the brain with electrodes on the scalp, removing the need for invasive surgery to implant them. (Source: Parkinson's Disease News From Medical News Today)
Source: Parkinson's Disease News From Medical News Today - June 1, 2017 Category: Neurology Tags: Neurology / Neuroscience Source Type: news

Deep Brain Stimulation Without Surgery
Using interfering high-frequency currents applied to the surface of the mouse skull, scientists can noninvasively target brain regions buried below the cortical surface. (Source: The Scientist)
Source: The Scientist - June 1, 2017 Category: Science Tags: Daily News,News & Opinion,The Scientist Source Type: news

State of Mind Episode 5: Out of the depths
Vito Randazzo has been suffering from severe depression for 18 years, and after nothing else worked, he turned to deep brain stimulation for help (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 31, 2017 Category: Consumer Health News Source Type: news

Cleveland Clinic, Boston Sci think deep brain stimulation can treat strokes
Illustration of a deep brain stimulation lead implanted in the cerebellar dentate nucleus for treatment of post-stroke motor deficits. [Image from Cleveland Clinic]The Cleveland Clinic is pioneering deep brain stimulation for stroke recovery, with an ongoing clinical trial to determine if Boston Scientific’s Vercise DBS system improves movement in recovering stroke patients. Dr. Andre Machado and his team performed the 6-hour deep brain stimulation surgery on Dec. 19, 2016. The procedure implanted electrodes into the cerebellum section of the brain. The deep brain stimulation electrodes emit small electric pulses whi...
Source: Mass Device - May 9, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Biotech Neuromodulation/Neurostimulation Boston Scientific Cleveland Clinic deep brain stimulation MedTech Source Type: news

From the Blogs: May ID Link-o-Rama / Deep Brain Stimulation & Subthalamic Nucleus (FREE)
By the Editors Take a look at what the NEJM Journal Watch bloggers are talking about right now: HIV … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 8, 2017 Category: Primary Care Source Type: news

Parkinson: Weight gain after deep brain stimulation
It was already known that people affected by Parkinson's disease, when subjected to deep brain stimulation, gained weight, but it was less clear why that was so. New research has now shown that the weight gain after implant has a multifactorial origin. The study monitored for the first time a group of patients before and after the intervention, assessing cognitive, psychological and behavioral aspects, providing important elements for preventative purposes. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 4, 2017 Category: Science Source Type: news

Parkinson: Weight gain after deep brain stimulation
(Scuola Internazionale Superiore di Studi Avanzati) It was already known that people affected by Parkinson's disease, when subjected to deep brain stimulation, gained weight, but it was less clear why that was so. New research by the International School for Advanced Studies -- SISSA in Trieste (Italy) has now shown that the weight gain after implant has a multifactorial origin. The study monitored for the first time a group of patients before and after the intervention, assessing cognitive, psychological and behavioral aspects, providing important elements for preventative purposes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 4, 2017 Category: Global & Universal Source Type: news

A pilot study of deep brain stimulation in treatment-resistant schizophrenia
This study's purpose is to describe the protocol and the preliminary results of the first seven cases of schizophrenia treated with DBS. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 25, 2017 Category: Science Source Type: news

Medtronic launches StealthStation S8 neurosurgery navigator
Medtronic (NYSE:MDT) said today it launched the next-gen S8 version of its StealthStation neurosurgical intraoperative imaging and navigation system The StealthStation S8 includes upgrades to its software interface, a 2-cart platform design and electromagnetic technology, the Fridley, Minn.-based company said. “Neuro-navigation and computer-based surgical guidance has become a standard part of neurosurgery practices today. The StealthStation helps me ensure complete resections as well as helps me minimize approach-related complications. I believe many neurosurgeons will be excited to see what the newest version ...
Source: Mass Device - April 24, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Imaging Neurological Surgical Medtronic Source Type: news

Could a Zap to the Brain Jog Failing Memory?
Deep brain stimulation appears to help, but much more research is needed, scientists say (Source: WebMD Health)
Source: WebMD Health - April 20, 2017 Category: Consumer Health News Source Type: news

Could a Zap to the Brain Jog Failing Memory?
Deep brain stimulation appears to help, but much more research is needed, scientists say Source: HealthDay Related MedlinePlus Pages: Memory (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - April 20, 2017 Category: Consumer Health News Source Type: news

Could a Zap to the Brain Jog Failing Memory?
THURSDAY, April 20, 2017 -- Can a slight charge of electricity improve an ailing memory? Maybe, according to new research from the University of Pennsylvania. Timed correctly, deep brain stimulation can help people whose memory is lapsing. The... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 20, 2017 Category: Journals (General) Source Type: news

DBS Appears to Improve Sleep Quality, Daytime Sleepiness in PD Patients DBS Appears to Improve Sleep Quality, Daytime Sleepiness in PD Patients
Patients with Parkinson ’ s disease (PD) slept better after undergoing deep brain stimulation (DBS) and had less daytime sleepiness in a new study in 50 patients.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 18, 2017 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Deep Brain Stimulation May Ease Tourette Tics
But neurology experts agree that more research is needed (Source: WebMD Health)
Source: WebMD Health - April 12, 2017 Category: Consumer Health News Source Type: news

Deep Brain Stimulation May Ease Tourette'Tics '
But neurology experts agree that more research is neededSource: HealthDay Related MedlinePlus Page: Tourette Syndrome (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - April 11, 2017 Category: Consumer Health News Source Type: news

Deep Brain Stimulation May Ease Tourette'Tics '
TUESDAY, April 11, 2017 -- Some young people with severe cases of Tourette syndrome may benefit from having electrodes implanted in the brain, a small study suggests. The procedure, known as deep brain stimulation (DBS), has long been used to treat... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 11, 2017 Category: Journals (General) Source Type: news

Study: Deep brain stim shown to improve Tourettes symptoms
Deep brain stimulation procedures have been shown to reduce “tics,” or involuntary movements or outbursts, experienced by young adult individuals with Tourette’s syndrome, according to a new study. Results from the study were published last Friday in the Journal of Neurosurgery. Study researchers said the new data adds to a growing body which support DBS as a safe and effective treatment for severe cases of Tourette’s syndrome, according to a release, and may help support eventual FDA approval of the procedure. “Our study shows that deep brain stimulation is a safe, effective treatment for you...
Source: Mass Device - April 11, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Neurological Neuromodulation/Neurostimulation Source Type: news

Deep brain stimulation may reduce severe Tourette ’ s syndrome
An experimental technique reduces the tics, or involuntary movements and vocal outbursts, associated with severe Tourette's syndrome in young adults, a study published Friday found. The surgical technique, called thalamic deep brain stimulation (DBS), sends electrical impulses to a specific area of the brain that reduces the tics, according to the study published in the Journal of […]Related:Physician recommendations about breast cancer screening vary, survey findsSurvey shows why doctors choose medicine and the challenges they faceMore than 1 in 5 U.S. adults are infected with cancer-causing HPV, CDC repo...
Source: Washington Post: To Your Health - April 7, 2017 Category: Consumer Health News Source Type: news

From the Blogs: Deep Brain Stimulation Targeting — The Globus Pallidus Internus (FREE)
By the Editors Physician assistant Bianca Belcher continues … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - April 3, 2017 Category: Primary Care Source Type: news

Deep brain stimulation provides long-term relief from severe depressions
Doctors have produced the first evidence of deep brain stimulation's lasting effectiveness in a four-year study. The method could serve in the future as an optional therapy for critically ill patients, suggests a new report. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 20, 2017 Category: Science Source Type: news

Deep Brain Stimulation Promising for Severe Anorexia Deep Brain Stimulation Promising for Severe Anorexia
Continuous DBS of the subcallosal cingulate significantly improved mood and body weight over 12 months in an open-label trial of women with chronic, severe anorexia.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - March 2, 2017 Category: Psychiatry Tags: Psychiatry News Source Type: news

Brain stimulation raises hopes for patients with drug-resistant high blood pressure
A Bristol team has used a deep brain stimulation technique to dramatically reduce a woman ’ s high blood pressure – the first time in the world the procedure has been carried out for hypertension. (Source: University of Bristol news)
Source: University of Bristol news - February 27, 2017 Category: Universities & Medical Training Tags: Research, Health; Faculty of Biomedical Sciences, School of Physiology and Pharmacology, Faculty of Biomedical Sciences; Press Release Source Type: news

Brain stimulation used in world first treatment of high blood pressure
A Bristol team has used a deep brain stimulation technique to dramatically reduce a woman ’ s high blood pressure – the first time in the world the procedure has been carried out for hypertension. The discovery raises hopes for patients with drug-resistant hypertension. (Source: University of Bristol news)
Source: University of Bristol news - February 27, 2017 Category: Universities & Medical Training Tags: Research, Health; Faculty of Biomedical Sciences, School of Physiology and Pharmacology, Faculty of Biomedical Sciences; Press Release Source Type: news